Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-28

FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Florida Pharmaceutical Products, LLC.)

View source ↗

Summary

The FDA approved a supplemental application for Abiraterone Acetate (generic) submitted by Florida Pharmaceutical Products, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)